These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1627440)

  • 1. In vivo and in vitro studies of the dopaminergic system in movement disorders.
    Playford ED; Brooks DJ
    Cerebrovasc Brain Metab Rev; 1992; 4(2):144-71. PubMed ID: 1627440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of clinical dopamine imaging.
    Lindsey KP; Gatley SJ
    Neuroimaging Clin N Am; 2006 Nov; 16(4):553-73, vii-viii. PubMed ID: 17148019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease.
    Chase TN; Engber TM; Mouradian MM
    Adv Neurol; 1996; 69():497-501. PubMed ID: 8615171
    [No Abstract]   [Full Text] [Related]  

  • 4. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
    Amenta F; Ricci A; Tayebati SK; Zaccheo D
    Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, diagnosis, and imaging of parkinsonian syndromes.
    Poewe W
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):333-8. PubMed ID: 8507902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.
    Thobois S; Vingerhoets F; Fraix V; Xie-Brustolin J; Mollion H; Costes N; Mertens P; Benabid AL; Pollak P; Broussolle E
    Arch Neurol; 2004 Nov; 61(11):1705-9. PubMed ID: 15534182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights.
    Laruelle M; Huang Y
    Q J Nucl Med; 2001 Jun; 45(2):124-38. PubMed ID: 11476162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
    Moerlein SM; Perlmutter JS; Markham J; Welch MJ
    J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter in vitro binding and in vivo imaging in the brain.
    Bergström KA; Tupala E; Tiihonen J
    Pharmacol Toxicol; 2001 Jun; 88(6):287-93. PubMed ID: 11453367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder.
    Berk M; Dodd S; Kauer-Sant'anna M; Malhi GS; Bourin M; Kapczinski F; Norman T
    Acta Psychiatr Scand Suppl; 2007; (434):41-9. PubMed ID: 17688462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
    Hume SP; Lammertsma AA; Myers R; Rajeswaran S; Bloomfield PM; Ashworth S; Fricker RA; Torres EM; Watson I; Jones T
    J Neurosci Methods; 1996 Aug; 67(2):103-12. PubMed ID: 8872875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
    Rascol OJ; Sabatini U; Chollet F; Montastruc JL; Marc-Vergnes JP; Rascol A
    Adv Neurol; 1993; 60():419-21. PubMed ID: 8420165
    [No Abstract]   [Full Text] [Related]  

  • 13. [The receptor binding study in vivo].
    Inoue O; Kobayashi K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):215-25. PubMed ID: 7975926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
    J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT and PET in Atypical Parkinsonism.
    Seibyl JP
    PET Clin; 2010 Jan; 5(1):65-74. PubMed ID: 27157483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress-induced movement disorders.
    Bodensteiner J
    Clin Pediatr (Phila); 2001 Jan; 40(1):53-4. PubMed ID: 11210088
    [No Abstract]   [Full Text] [Related]  

  • 17. Movement disorders.
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):407-18. PubMed ID: 1623271
    [No Abstract]   [Full Text] [Related]  

  • 18. Movement disorders.
    Curr Opin Neurol; 1995 Aug; 8(4):B124-37. PubMed ID: 7582037
    [No Abstract]   [Full Text] [Related]  

  • 19. Movement disorders.
    Curr Opin Neurol; 1998 Aug; 11(4):392-412. PubMed ID: 9725086
    [No Abstract]   [Full Text] [Related]  

  • 20. Movement disorders.
    Curr Opin Neurol; 1996 Aug; 9(4):B90-9. PubMed ID: 8858195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.